Skip to content
Reckitt Benckiser
Search
Join RB’s networks
Facebook
LinkedIn
Twitter
YouTube
Google Plus
Weibo
RB Early Life Blog
Share
Sitemap
HTML version
Text only version
RB worldwide
Global locations
Executive Committee
The Board
RB history
Vision and values
Contact us
Careers & students
Apply now
Why join us?
Jobs for professionals
Graduates & Interns
What it's like at RB
Brand Me
Just for fun
Innovators
Products
People
Awards
Our brands
Powerbrands on the shelf
Products around the home
Commercial break
Search RB Brands A-Z
Category performance
Healthcare Brands Employee Reporting
Suboxone, Subutex & Temgesic adverse events reporting
Our responsibility
betterbusiness
Our Home Our Planet
Trees for Change
Community
Healthier kids Happier homes
Policies & reports
Contact us
Investors & media
Announcements & presentations
The talk about RB
Investor information
Category performance
Corporate governance
Share price information
Shareholder information
Patient organisation donations
Joint working executive summaries
Newsletter registration
Financial support for Healthcare Professionals
Contact us
Home
>
Investors & media
>
Announcements & presentations
>
2006
>
Completion of Acquisition of Boots Healthcare International
Investors & media
Announcements & presentations
The talk about RB
Investor information
Category performance
Corporate governance
Share price information
Shareholder information
Patient organisation donations
Joint working executive summaries
Newsletter registration
Financial support for Healthcare Professionals
Contact us
Announcements
RB Press release - 01/02/2006
Completion of Acquisition of Boots Healthcare International
Reckitt Benckiser plc (RB.L) today announced that the acquisition of Boots Healthcare International (BHI) has been completed with effect from 1st February 2006.
Bart Becht, Chief Executive Officer of Reckitt Benckiser, commented today:-
"We are excited at getting ownership of BHI. It will give us a platform for additional growth at very attractive margins. BHI brings three new Power Brands in Nurofen, Strepsils and Clearasil whose distribution can be substantially expanded over time. In 2006, our major focus for this business will be on successful integration and extracting the promised synergies while gradually preparing the business for growth."
Reckitt Benckiser is due to announce preliminary results for 2005 on Wednesday 8th February.
For Further Information
Reckitt Benckiser plc Tel +44 (0) 1753 217 800
Fiona Fong Head of Corporate Communications (press calls)
Mark Wilson Corporate Controller & Investor Relations Manager (investor calls)
Tim Spratt Financial Dynamics telephone +44 (0) 207 831 3113
Note for Editors
On 7th October 2005, Reckitt Benckiser announced the acquisition of Boots Healthcare International (BHI) from Boots Group PLC for a consideration of £1,926 million in cash. The revenues of the combined Health and Personal Care business will exceed £1 billion, an increase of 80% and will represent c.25% of the enlarged Reckitt Benckiser. BHI brings 3 powerful brands: Nurofen, one of Europe's leading brands of analgesic and leading ibuprofen brands; Strepsils, the global number 1 medicated sore throat brand and Clearasil, the global number 1 anti acne brand, to combine with Reckitt Benckiser's Gaviscon and Lemsip. The company will have a strong presence in the key categories of analgesics, cough/cold/flu, upper gastro-intestinal and medicated skincare.
Reckitt Benckiser is the world leader in household cleaning, excluding laundry, and has a major presence in health and personal care. The Company is truly global, with over 60 operating companies and over 40 manufacturing facilities worldwide and has sales in 180 countries. The Company employs 20,000 people around the world. Reckitt Benckiser is headquartered in Slough just outside London and is listed on the London With a market capitalization of c.£13.5bn it ranks among the top 30 UK Reckitt Benckiser had net revenues of £3.87bn, operating profit of £770m, and net income of £586m in 2004. stock exchange. listed companies.
Print this page
< Go back to index